ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This research study is studying a drug intervention as a possible chemoprevention strategy
for colorectal cancer.
The name of the study intervention involved in this study is:
- Low Dose Aspirin
Phase:
Early Phase 1
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
National Cancer Institute/NIH/DHHS (NCI) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institutes of Health (NIH)